{"id":148,"date":"2025-12-04T18:21:14","date_gmt":"2025-12-04T18:21:14","guid":{"rendered":"https:\/\/www.research.colostate.edu\/orcc\/institutional-biosafety-committee\/public-comment\/"},"modified":"2025-12-04T18:25:10","modified_gmt":"2025-12-04T18:25:10","slug":"public-comment","status":"publish","type":"page","link":"https:\/\/www.research.colostate.edu\/orcc\/institutional-biosafety-committee\/policies-regulations\/public-comment\/","title":{"rendered":"Public Comment"},"content":{"rendered":"\n<p><em>Revised Approved \u2013 August 8, 2018 Original Approved by the IBC on December 10, 2008<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Introduction<\/h2>\n\n\n\n<p>Section IV-B-2-a-(7) of the NIH Guidelines states, \u201c\u2026If public comments are made on Institutional Biosafety Committee actions, the institution shall forward both the public comments and the Institutional Biosafety Committee\u2019s response to the National Institutes of Health: Office of Science Policy.\u201d<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Policy<\/h2>\n\n\n\n<p>Any comments made by members of the public regarding the actions of Colorado State University\u2019s Institutional Biosafety Committee (IBC) shall be immediately forwarded to the IBC Coordinator. The IBC Coordinator will forward such comments to the Institutional Official (IO) and the IBC and prepare the initial response within 72 hours. The IBC will finalize a response, which the IBC Coordinator will forward to the IO and the Office of General Counsel (OGC) for approval. Once the response has been approved, the IBC Coordinator will forward the response to the individual(s) who made the comments. In addition, the IBC Coordinator will forward both the public comments and the IBC\u2019s response to the NIH OSP.\u00a0<br><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Revised Approved \u2013 August 8, 2018 Original Approved by the IBC on December 10, 2008 Introduction Section IV-B-2-a-(7) of the NIH Guidelines states, \u201c\u2026If public comments are made on Institutional Biosafety Committee actions, the institution shall forward both the public comments and the Institutional Biosafety Committee\u2019s response to the National Institutes of Health: Office of [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":149,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":true,"footnotes":""},"microsite":[10],"class_list":["post-148","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.research.colostate.edu\/orcc\/wp-json\/wp\/v2\/pages\/148","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.research.colostate.edu\/orcc\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.research.colostate.edu\/orcc\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.research.colostate.edu\/orcc\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.research.colostate.edu\/orcc\/wp-json\/wp\/v2\/comments?post=148"}],"version-history":[{"count":0,"href":"https:\/\/www.research.colostate.edu\/orcc\/wp-json\/wp\/v2\/pages\/148\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.research.colostate.edu\/orcc\/wp-json\/wp\/v2\/pages\/149"}],"wp:attachment":[{"href":"https:\/\/www.research.colostate.edu\/orcc\/wp-json\/wp\/v2\/media?parent=148"}],"wp:term":[{"taxonomy":"microsite","embeddable":true,"href":"https:\/\/www.research.colostate.edu\/orcc\/wp-json\/wp\/v2\/microsite?post=148"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}